NCT00119496 - Rosiglitazone Versus Theophylline in Asthmatic Smokers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

June 30, 2007

Conditions

Asthma

Interventions

DRUG

rosiglitazone

oral tablet, 4mg bd for 4 weeks

DRUG

theophylline

Oral theophylline, 200mg bd

DRUG

beclomethasone

inhaled beclomethasone, 200mcg bd

DRUG

inhaled beclomethasone and oral theophylline

inhaled beclomethasone (400mcg/day), oral theophylline (400mg/day)

Trial Locations (1)

Asthma Research Group, Gartnavel General Hospital, Glasgow